Regulation of protease‐activated receptor signaling by post‐translational modifications

Protease‐activated receptors (PARs) are a unique family of G‐protein‐coupled receptors (GPCRs) that are irreversibly activated following proteolytic cleavage of their extracellular N‐terminus. PARs play critical functions in hemostasis, thrombosis, inflammation, embryonic development, and cancer progression. Because of the irreversible proteolytic nature of PAR activation, signaling by the receptors is tightly regulated. Three distinct processes including desensitization, internalization, and lysosomal degradation, regulate the temporal and spatial aspects of activated PAR signaling. Post‐translational modifications play a critical role in regulating each of these processes and here we review the nature of PAR post‐translational modifications and their importance in signal regulation. The PARs are activated by numerous proteases, and some can elicit distinct cellular responses, how this biased agonism is determined is unknown. Further study of the function of post‐translational modifications of the PARs will lead to a greater understanding of the physiological regulation of baised agonism and how PAR signaling is precisely controlled in different cellular contexts. © 2011 IUBMB IUBMB Life, 63(6): 403–411, 2011

[1]  H. Pan,et al.  Arrestin domain‐containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the β2‐adrenergic receptor , 2010, EMBO reports.

[2]  S. Traynelis,et al.  PAR1 and PAR2 Couple to Overlapping and Distinct Sets of G Proteins and Linked Signaling Pathways to Differentially Regulate Cell Physiology , 2010, Molecular Pharmacology.

[3]  Michael R Dores,et al.  Signal transduction by protease‐activated receptors , 2010, British journal of pharmacology.

[4]  J. Pin,et al.  Differential association modes of the thrombin receptor PAR1 with Gαil, Gα12, and β‐arrestin 1 , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  M. Maoz,et al.  Protease-activated Receptor-1 (PAR1) Acts via a Novel Gα13-Dishevelled Axis to Stabilize β-Catenin Levels* , 2010, The Journal of Biological Chemistry.

[6]  A. Pshezhetsky,et al.  Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. , 2010, Cellular signalling.

[7]  J. Trejo,et al.  Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization* , 2009, The Journal of Biological Chemistry.

[8]  G. Cottrell,et al.  Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2* , 2009, The Journal of Biological Chemistry.

[9]  J. Trejo,et al.  Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways* , 2009, The Journal of Biological Chemistry.

[10]  V. Trivedi,et al.  Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site , 2009, Cell.

[11]  A. Marchese,et al.  G protein-coupled receptor sorting to endosomes and lysosomes. , 2008, Annual review of pharmacology and toxicology.

[12]  R. Lefkowitz,et al.  Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation* , 2007, Journal of Biological Chemistry.

[13]  A. Marchese,et al.  Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1 , 2007, The Journal of cell biology.

[14]  J. Trejo,et al.  Clathrin‐Dependent Mechanisms of G Protein‐coupled Receptor Endocytosis , 2007, Traffic.

[15]  J. Trejo,et al.  Protease-activated receptor signaling: new roles and regulatory mechanisms , 2007, Current opinion in hematology.

[16]  Roger L. Williams,et al.  The emerging shape of the ESCRT machinery , 2007, Nature Reviews Molecular Cell Biology.

[17]  A. Schömig,et al.  Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Milano,et al.  Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.

[19]  V. Gurevich,et al.  Arrestins: ubiquitous regulators of cellular signaling pathways , 2006, Genome Biology.

[20]  Hiromu Suzuki,et al.  Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization. , 2006, Cancer research.

[21]  T. Magnuson,et al.  An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer-, Hrs-, and Tsg101-independent functions of sorting nexins. , 2005, Molecular biology of the cell.

[22]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[23]  G. Cottrell,et al.  c-Cbl Mediates Ubiquitination, Degradation, and Down-regulation of Human Protease-activated Receptor 2* , 2005, Journal of Biological Chemistry.

[24]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[25]  J. Trejo,et al.  Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.

[26]  J. Trejo,et al.  A Tyrosine-based Sorting Signal Regulates Intracellular Trafficking of Protease-activated Receptor-1 , 2004, Journal of Biological Chemistry.

[27]  J. Trejo,et al.  Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation* , 2004, Journal of Biological Chemistry.

[28]  S. Compton Glycosylation and proteinase‐activated receptor function , 2003 .

[29]  T. Kohout,et al.  β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation* , 2002, The Journal of Biological Chemistry.

[30]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[31]  H. Hamm,et al.  A Novel Bifunctional Phospholipase C That Is Regulated by Gα12 and Stimulates the Ras/Mitogen-activated Protein Kinase Pathway* , 2001, The Journal of Biological Chemistry.

[32]  A. Malik,et al.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[34]  S. Coughlin,et al.  Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail. , 1999, Biochemistry.

[35]  M. Wheatley,et al.  Glycosylation of G-protein-coupled receptors for hormones central to normal reproductive functioning: its occurrence and role. , 1999, Human reproduction update.

[36]  G. Schultz,et al.  Differential Involvement of Gα12 and Gα13 in Receptor-mediated Stress Fiber Formation* , 1999, The Journal of Biological Chemistry.

[37]  P. Sigler,et al.  A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin , 1999, Cell.

[38]  S. Coughlin,et al.  The Cytoplasmic Tails of Protease-activated Receptor-1 and Substance P Receptor Specify Sorting to Lysosomes versusRecycling* , 1999, The Journal of Biological Chemistry.

[39]  S. Coughlin,et al.  The Cloned Thrombin Receptor Is Necessary and Sufficient for Activation of Mitogen-activated Protein Kinase and Mitogenesis in Mouse Lung Fibroblasts , 1996, The Journal of Biological Chemistry.

[40]  A. Tordai,et al.  Tunicamycin inhibits the expression of functional thrombin receptors on human T-lymphoblastoid cells. , 1995, Biochemical and biophysical research communications.

[41]  R. Reithmeier,et al.  Asparagine-linked oligosaccharides are localized to single extracytosolic segments in multi-span membrane glycoproteins. , 1994, The Biochemical journal.

[42]  J. Chen,et al.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.

[43]  J. Williamson,et al.  G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. , 1994, The Journal of biological chemistry.

[44]  G. Schultz,et al.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[46]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[47]  G. Schultz,et al.  Differential involvement of Galpha12 and Galpha13 in receptor-mediated stress fiber formation. , 1999, The Journal of biological chemistry.

[48]  P. Sigler,et al.  The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. , 1999, Cell.

[49]  M. Simon,et al.  Defective platelet activation in G alpha(q)-deficient mice. , 1997, Nature.